Bridget Cole

Company: Nocion Therapeutics

Job title: Senior Vice President Drug Discovery

Seminars:

Championing a Novel Approach to Atopic Dermatitis Therapy Through Silencing Nociceptors with CSCBs 2:00 pm

Utilizing a proprietary platform to develop Charged Sodium Channel Blocker (CSCB) small molecules Demonstrating efficacy in symptom relief of atopic dermatitis and pruritus Inhibition of neurogenic inflammation leading to significant anti-inflammatory effect (reduction in clinical score, cytokine levels)Read more

day: Day 2 PM - Track A